Cite
HARVARD Citation
Kontandreopoulou, C. et al. (2022). Bone marrow ribonucleotide reductase mRNA levels and methylation status as prognostic factors in patients with myelodysplastic syndrome treated with 5-Azacytidine. Leukemia & lymphoma. 63 (3), pp. 729-737. [Online].